Zhen 'ao Group is located in Shuang Gang, with a total area of nearly 600,000 square meters. It has six production holding subsidiaries, including Dalian Zhenao Pharmaceutical Co., Ltd., Dalian Zhenao Biotechnology Co., Ltd., Shanghai Zhenao Biotechnology Co., Ltd., Dalian Shuangdi Biotechnology Co., Ltd., Fujian Zhenao Nucleic Acid Co., Ltd. and Dalian Zhenao Import and Export Co., Ltd., and has more than 400 varieties in 7 series, including medicines, health products, cosmetics, functional textiles, nucleic acid raw materials and healthy water. Zhenao has a sound marketing network in China and nearly 40 first-class marketing management institutions.

Zhen 'ao Group is the largest nucleic acid industrialization base in China, and the only nucleic acid enterprise in the world that integrates the whole product chain of nucleotide upstream and downstream. The domestic market share of nucleic acid raw materials is over 85%. Zhen 'ao nucleic acid series health care products have been tested by people in health-related product evaluation bases designated by Shanghai Fudan University, Tongji University and other national authorities, and proved to be effective and safe, and the products have been selling well for more than ten years. Rare ribonucleic acid (RNA) is the only RNA product in the world that has passed GMA-SAFE (American Food Manufacturers Association-Excellent Food Producer Audit) certification. Enterprises were invited to participate in the formulation of the first international standard for ribonucleic acid for food. Zhen 'ao 5' nucleotide fully meets the requirements of the latest FCC (American Codex Alimentarius) standard and has been used as a food additive by many top multinational companies around the world. This project has been listed as the project of the National Development and Reform Commission to revitalize the old industrial base in Northeast China. In the field of medicine, cardiotonic peptide for injection, a national first-class new drug independently developed by Zhen 'ao, is a national key scientific and technological project in the Ninth Five-Year Plan and a national key scientific and technological project in the Tenth Five-Year Plan. It has passed four clinical trials, obtained the certificate of new drug, and is fully listed.

Zhen 'ao Group has established long-term and stable scientific research cooperation with more than a dozen scientific research institutes and hundreds of scientists at home and abroad. 12 Nobel Prize winners, including Dr. Zinkernagel, former president of the International Federation for Immunization, walked into the Zhen 'ao Life Park to evaluate and guide the scientific research projects and experimental activities of Zhen 'ao. Up to now, Zhen 'ao Group has nearly 100 patents and has been rated as "National Intellectual Property Pilot Unit".

Zhen 'ao Group implements the quality policy of "ten thousand rather than one thousand" and strictly implements the international safety standards for healthy food and drug production. It has successively passed the ISO900 1 International Quality Management System Certification, HACCP International Food Safety Prevention and Control System Certification, ISO22000 International Food Safety Management System Certification, ISO1400/International Environmental Management System Certification, GMP Certification of Drugs and Health Foods, etc. In addition, Zhen 'ao has also obtained the enterprise registration qualification and product customs clearance inspection of the US FDA, and the health care product access certification of the Japanese Ministry of Health and Welfare.